Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.

Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.

Item
http://www.wikidata.org/entity/Q37596743
Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite RatioCommentary on Culverhouse et al. (2014): How genomics can bring us towards health equityGene by Environment Investigation of Incident Lung Cancer Risk in African-Americans.Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activityGenetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensityDistribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.CYP2A6 Genetic Variation Alters Striatal-Cingulate Circuits, Network Hubs, and Executive Processing in Smokers.CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not?Lung Cancer Health Disparities.
P2860

Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.

Item
http://www.wikidata.org/entity/Q37596743
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel CYP2A6 variants identifi ...... tabolism in vitro and in vivo.
@en
Novel CYP2A6 variants identifi ...... tabolism in vitro and in vivo.
@nl
type
label
Novel CYP2A6 variants identifi ...... tabolism in vitro and in vivo.
@en
Novel CYP2A6 variants identifi ...... tabolism in vitro and in vivo.
@nl
prefLabel
Novel CYP2A6 variants identifi ...... tabolism in vitro and in vivo.
@en
Novel CYP2A6 variants identifi ...... tabolism in vitro and in vivo.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Novel CYP2A6 variants identifi ...... tabolism in vitro and in vivo.
@en
P2093
P2860
P304
P31
P356
10.1097/FPC.0000000000000026
P433
P478
P50
P577
P698
P932